LT3449B - New use of ropivacaine - Google Patents

New use of ropivacaine Download PDF

Info

Publication number
LT3449B
LT3449B LTIP1958A LTIP1958A LT3449B LT 3449 B LT3449 B LT 3449B LT IP1958 A LTIP1958 A LT IP1958A LT IP1958 A LTIP1958 A LT IP1958A LT 3449 B LT3449 B LT 3449B
Authority
LT
Lithuania
Prior art keywords
ropivacaine
blocking
weight
sensory
infusion
Prior art date
Application number
LTIP1958A
Other languages
English (en)
Lithuanian (lt)
Inventor
Arne Eek
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20390432&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT3449(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Ab filed Critical Astra Ab
Publication of LTIP1958A publication Critical patent/LTIP1958A/xx
Publication of LT3449B publication Critical patent/LT3449B/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Hydrogenated Pyridines (AREA)
  • Insulation, Fastening Of Motor, Generator Windings (AREA)
  • Particle Accelerators (AREA)
  • Medicinal Preparation (AREA)
  • Air Conditioning Control Device (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Electromechanical Clocks (AREA)
  • Steroid Compounds (AREA)
LTIP1958A 1993-06-28 1994-06-17 New use of ropivacaine LT3449B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19939302218A SE9302218D0 (sv) 1993-06-28 1993-06-28 New use

Publications (2)

Publication Number Publication Date
LTIP1958A LTIP1958A (en) 1995-01-31
LT3449B true LT3449B (en) 1995-10-25

Family

ID=20390432

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP1958A LT3449B (en) 1993-06-28 1994-06-17 New use of ropivacaine

Country Status (32)

Country Link
US (2) US5670524A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0706395B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP3725541B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1074918C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE216237T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR9406865A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2165446C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CZ (1) CZ283300B6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (2) DE69430427T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK0706395T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EE (1) EE03205B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2099048T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI956269A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR970300013T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU218949B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL110006A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IS (1) IS4174A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LT (1) LT3449B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LV (1) LV12918B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY119360A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO955313L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ268110A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH31258A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL175518B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT706395E (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU (1) RU2152215C1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SA (1) SA94150010B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE9302218D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SG (1) SG49078A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SK (1) SK280111B6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW285640B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1995000148A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use
AU742488B2 (en) * 1997-07-21 2002-01-03 Darwin Discovery Limited Levobupivacaine and its use
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
WO2009061497A1 (en) 2007-11-07 2009-05-14 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
JP2015516411A (ja) 2012-05-10 2015-06-11 ペインレフォーム リミテッド 疎水性有効成分のデポー製剤及びその調製方法
AU2013257727B2 (en) * 2012-05-10 2016-04-28 Cellixbio Private Limited Compositions and methods for the treatment of local pain
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
SG11201506789PA (en) 2013-02-28 2015-09-29 Dermira Inc Glycopyrrolate salts
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985000599A1 (en) 1983-08-01 1985-02-14 A/S Apothekernes Laboratorium For Specialpraeparat L-N-n-PROPYLPIPECOLIC ACID-2,6-XYLIDIDE AND METHOD FOR PREPARING THE SAME

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985000599A1 (en) 1983-08-01 1985-02-14 A/S Apothekernes Laboratorium For Specialpraeparat L-N-n-PROPYLPIPECOLIC ACID-2,6-XYLIDIDE AND METHOD FOR PREPARING THE SAME

Also Published As

Publication number Publication date
ATE216237T1 (de) 2002-05-15
SE9302218D0 (sv) 1993-06-28
NZ268110A (en) 1999-06-29
EE03205B1 (et) 1999-08-16
AU692161B2 (en) 1998-06-04
NO955313D0 (no) 1995-12-27
CZ283300B6 (cs) 1998-02-18
HU218949B (hu) 2001-01-29
FI956269A7 (fi) 1995-12-27
GR970300013T1 (en) 1997-05-31
JP3725541B2 (ja) 2005-12-14
SG49078A1 (en) 1998-05-18
JPH09500620A (ja) 1997-01-21
PH31258A (en) 1998-06-18
IL110006A (en) 1999-01-26
HU9503692D0 (en) 1996-02-28
CN1126435A (zh) 1996-07-10
DE69430427T2 (de) 2002-11-14
WO1995000148A1 (en) 1995-01-05
SK280111B6 (sk) 1999-08-06
MY119360A (en) 2005-05-31
EP0706395B1 (en) 2002-04-17
FI956269L (fi) 1995-12-27
HK1010344A1 (en) 1999-06-17
SA94150010B1 (ar) 2006-04-04
US5670524A (en) 1997-09-23
CN1074918C (zh) 2001-11-21
US5834489A (en) 1998-11-10
DE69430427D1 (de) 2002-05-23
LV12918B (en) 2003-03-20
CA2165446A1 (en) 1995-01-05
HUT75115A (en) 1997-04-28
IL110006A0 (en) 1994-11-11
PL175518B1 (pl) 1999-01-29
FI956269A0 (fi) 1995-12-27
AU7086694A (en) 1995-01-17
TW285640B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1996-09-11
RU2152215C1 (ru) 2000-07-10
SK164695A3 (en) 1996-07-03
NO955313L (no) 1995-12-27
CZ336495A3 (en) 1996-06-12
DE706395T1 (de) 1997-09-04
ES2099048T1 (es) 1997-05-16
CA2165446C (en) 2005-07-05
LTIP1958A (en) 1995-01-31
ES2099048T3 (es) 2002-11-16
BR9406865A (pt) 1996-03-26
IS4174A (is) 1994-12-29
PL312198A1 (en) 1996-04-01
DK0706395T3 (da) 2002-07-22
PT706395E (pt) 2002-09-30
EP0706395A1 (en) 1996-04-17

Similar Documents

Publication Publication Date Title
Cooper et al. Patient-controlled extradural analgesia with bupivacaine, fentanyl, or a mixture of both, after Caesarean section.
Klamt et al. Postoperative analgesic effect of intrathecal neostigmine and its influence on spinal anaesthesia
KR20150131330A (ko) 지속성 국소 마취용 네오삭시톡신 조합 제형
JP2008533140A (ja) 術後鎮痛剤の低減
Khan et al. Comparison of intrathecal fentanyl and buprenorphine in urological surgery
Grass Fentanyl: Clinical use as postoperative analgesic—Epidural/intrathecal rout
LT3449B (en) New use of ropivacaine
Nuuttnen et al. Diclofenac and oxycodone in treatment of postoperative pain: a double‐blind trial
US5945435A (en) Levobupivacaine and its use
AU692161C (en) Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
Atallah et al. Presurgical analgesia in children subjected to hypospadias repair
WO2022175973A1 (en) An injectable composition for long term delivery of nalbuphine or nalbuphine ester prodrug or its salts and use thereof
HK1010344B (en) Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
KR102118227B1 (ko) 척추 투여용 과포화 아세타미노펜 주사 용액
DE69816790T2 (de) Verbesserung der opioid-toleranz durch hemmung der induzierbaren stickstoffoxid-synthase zur behandlung von schmerzen
AU7231291A (en) Use of local anaesthetic agents in the manufacture of pharmaceutical preparations for iontophoresis
Rosenberg Use of nerve block techniques for postoperative analgesia
De Castro et al. Side effects
IE911793A1 (en) Use of local anaesthetic agents in the manufacture of¹pharmaceutical preparations for iontophoresis
CZ232391A3 (cs) Použití látek s lokálně anestetlckým účinkem pro výrobu farmaceutických prostředků k iontoforéze

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 20100617